Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis
- PMID: 9593173
- PMCID: PMC105813
- DOI: 10.1128/AAC.42.5.1295
Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis
Abstract
An A1400G mutation of the rrs gene was identified in Mycobacterium tuberculosis (MTB) strain ATCC 35827 and in 13 MTB clinical isolates resistant to amikacin-kanamycin (MICs, >128 microg/ml). High-level cross-resistance may result from such a mutation since MTB has a single copy of the rrs gene. Another mechanism(s) may account for high-level amikacin-kanamycin resistance in two mutants and lower levels of resistance in four clinical isolates, all lacking the A1400G mutation.
References
-
- Alangaden G J, Igno F R, Zvonok N M, Manavathu E K, Lerner S A. Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, D.C: American Society for Microbiology; 1996. Mechanism(s) of amikacin and streptomycin resistance in Mycobacterium tuberculosis, abstr. C136; p. 58.
-
- Allen B W, Mitchison D A, Chan Y C, Yew W W, Allan W G L, Girling D J. Amikacin in the treatment of pulmonary tuberculosis. Tubercle. 1983;64:111–118. - PubMed
-
- Beauclerk A A D, Cundliffe E. Sites of action of two ribosomal RNA methylases responsible for resistance to aminoglycosides. J Mol Biol. 1987;193:661–671. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
